Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
24.53 USD | -3.95% | -3.61% | -20.85% |
20/05 | Insmed Lung Infections Treatment Study Shows Improvement | MT |
15/05 | Goldman Sachs Adjusts Price Target on Insmed to $49 From $40, Maintains Buy Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-20.85% | 3.65B | |
+8.63% | 114B | |
+13.17% | 107B | |
-12.76% | 22.22B | |
-3.99% | 21.28B | |
-7.19% | 17.51B | |
-39.93% | 17.17B | |
+6.67% | 14.14B | |
+33.90% | 12.2B | |
-28.60% | 7.83B |
- Stock Market
- Equities
- INSM Stock
- News Insmed Incorporated
- BofA Securities Starts Insmed at Buy With $39 Price Target